Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

9.66

-0.07 (-0.72%)

At close: Aug 22, 2025, 1:45 PM

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-14.37M	-9.31M	-8.78M	-4.18M	-5.45M	-2.18M	-2.04M	-2.11M
Depreciation & Amortization	-620K	5K	-121K	87K	48K	2K	25K	26K
Stock-Based Compensation	634K	233K	173K	145K	54K	67K	69K	72K
Other Working Capital	n/a	-3M	-378K	488K	539K	126K	-238K	-260K
Other Non-Cash Items	4.51M	41K	185K	91K	-41K	238K	97K	742K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-2.36M	815K	-96K	1.17M	-319K	694K	-316K
Operating Cash Flow	-9.84M	-11.39M	-7.73M	-3.96M	-4.21M	-2.19M	-1.16M	-1.58M
Capital Expenditures	-91K	n/a	-6K	-5K	-93K	-5K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-124.65M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	9.5M	12.03M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-11.89M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	9.41M	-112.62M	-11.89M	-5K	-93K	-5K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-71K	n/a	-1.18M	64K	82.94M	n/a	n/a	n/a
Financial Cash Flow	-71K	88.88M	-1.01M	64K	82.94M	n/a	n/a	n/a
Net Cash Flow	-506K	-35.14M	-20.64M	-3.9M	78.63M	-2.19M	-1.16M	-1.58M
Free Cash Flow	-9.94M	-11.39M	-7.73M	-3.96M	-4.31M	-2.19M	-1.16M	-1.58M